Cargando…

Pentobarbital Produces Activation and Block of α(1)β(2)γ(2S) GABA(A) Receptors in Rapidly Perfused Whole Cells and Membrane Patches: Divergent Results Can Be Explained by Pharmacokinetics

Millimolar concentrations of the barbiturate pentobarbital (PB) activate γ-aminobutyric acid (GABA) type A receptors (GABARs) and cause blockade reported by a paradoxical current increase or “tail” upon washout. To explore the mechanism of blockade, we investigated PB-triggered currents of recombina...

Descripción completa

Detalles Bibliográficos
Autores principales: Gingrich, Kevin J., Burkat, Paul M., Roberts, William A.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638204/
https://www.ncbi.nlm.nih.gov/pubmed/19171770
http://dx.doi.org/10.1085/jgp.200810081
_version_ 1782164401795629056
author Gingrich, Kevin J.
Burkat, Paul M.
Roberts, William A.
author_facet Gingrich, Kevin J.
Burkat, Paul M.
Roberts, William A.
author_sort Gingrich, Kevin J.
collection PubMed
description Millimolar concentrations of the barbiturate pentobarbital (PB) activate γ-aminobutyric acid (GABA) type A receptors (GABARs) and cause blockade reported by a paradoxical current increase or “tail” upon washout. To explore the mechanism of blockade, we investigated PB-triggered currents of recombinant α(1)β(2)γ(2S) GABARs in whole cells and outside-out membrane patches using rapid perfusion. Whole cell currents showed characteristic bell-shaped concentration dependence where high concentrations triggered tail currents with peak amplitudes similar to those during PB application. Tail current time courses could not be described by multi-exponential functions at high concentrations (≥3,000 μM). Deactivation time course decayed over seconds and was slowed by increasing PB concentration and application time. In contrast, macropatch tail currents manifested eightfold greater relative amplitude, were described by multi-exponential functions, and had millisecond rise times; deactivation occurred over fractions of seconds and was insensitive to PB concentration and application time. A parsimonious gating model was constructed that accounts for macropatch results (“patch” model). Lipophilic drug molecules migrate slowly through cells due to avid partitioning into lipophilic subcellular compartments. Inclusion of such a pharmacokinetic compartment into the patch model introduced a slow kinetic component in the extracellular exchange time course, thereby providing recapitulation of divergent whole cell results. GABA co-application potentiated PB blockade. Overall, the results indicate that block is produced by PB concentrations sixfold lower than for activation involving at least three inhibitory PB binding sites, suggest a role of blocked channels in GABA-triggered activity at therapeutic PB concentrations, and raise an important technical question regarding the effective rate of exchange during rapid perfusion of whole cells with PB.
format Text
id pubmed-2638204
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-26382042009-08-01 Pentobarbital Produces Activation and Block of α(1)β(2)γ(2S) GABA(A) Receptors in Rapidly Perfused Whole Cells and Membrane Patches: Divergent Results Can Be Explained by Pharmacokinetics Gingrich, Kevin J. Burkat, Paul M. Roberts, William A. J Gen Physiol Article Millimolar concentrations of the barbiturate pentobarbital (PB) activate γ-aminobutyric acid (GABA) type A receptors (GABARs) and cause blockade reported by a paradoxical current increase or “tail” upon washout. To explore the mechanism of blockade, we investigated PB-triggered currents of recombinant α(1)β(2)γ(2S) GABARs in whole cells and outside-out membrane patches using rapid perfusion. Whole cell currents showed characteristic bell-shaped concentration dependence where high concentrations triggered tail currents with peak amplitudes similar to those during PB application. Tail current time courses could not be described by multi-exponential functions at high concentrations (≥3,000 μM). Deactivation time course decayed over seconds and was slowed by increasing PB concentration and application time. In contrast, macropatch tail currents manifested eightfold greater relative amplitude, were described by multi-exponential functions, and had millisecond rise times; deactivation occurred over fractions of seconds and was insensitive to PB concentration and application time. A parsimonious gating model was constructed that accounts for macropatch results (“patch” model). Lipophilic drug molecules migrate slowly through cells due to avid partitioning into lipophilic subcellular compartments. Inclusion of such a pharmacokinetic compartment into the patch model introduced a slow kinetic component in the extracellular exchange time course, thereby providing recapitulation of divergent whole cell results. GABA co-application potentiated PB blockade. Overall, the results indicate that block is produced by PB concentrations sixfold lower than for activation involving at least three inhibitory PB binding sites, suggest a role of blocked channels in GABA-triggered activity at therapeutic PB concentrations, and raise an important technical question regarding the effective rate of exchange during rapid perfusion of whole cells with PB. The Rockefeller University Press 2009-02 /pmc/articles/PMC2638204/ /pubmed/19171770 http://dx.doi.org/10.1085/jgp.200810081 Text en © 2009 Gingrich et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jgp.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Article
Gingrich, Kevin J.
Burkat, Paul M.
Roberts, William A.
Pentobarbital Produces Activation and Block of α(1)β(2)γ(2S) GABA(A) Receptors in Rapidly Perfused Whole Cells and Membrane Patches: Divergent Results Can Be Explained by Pharmacokinetics
title Pentobarbital Produces Activation and Block of α(1)β(2)γ(2S) GABA(A) Receptors in Rapidly Perfused Whole Cells and Membrane Patches: Divergent Results Can Be Explained by Pharmacokinetics
title_full Pentobarbital Produces Activation and Block of α(1)β(2)γ(2S) GABA(A) Receptors in Rapidly Perfused Whole Cells and Membrane Patches: Divergent Results Can Be Explained by Pharmacokinetics
title_fullStr Pentobarbital Produces Activation and Block of α(1)β(2)γ(2S) GABA(A) Receptors in Rapidly Perfused Whole Cells and Membrane Patches: Divergent Results Can Be Explained by Pharmacokinetics
title_full_unstemmed Pentobarbital Produces Activation and Block of α(1)β(2)γ(2S) GABA(A) Receptors in Rapidly Perfused Whole Cells and Membrane Patches: Divergent Results Can Be Explained by Pharmacokinetics
title_short Pentobarbital Produces Activation and Block of α(1)β(2)γ(2S) GABA(A) Receptors in Rapidly Perfused Whole Cells and Membrane Patches: Divergent Results Can Be Explained by Pharmacokinetics
title_sort pentobarbital produces activation and block of α(1)β(2)γ(2s) gaba(a) receptors in rapidly perfused whole cells and membrane patches: divergent results can be explained by pharmacokinetics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638204/
https://www.ncbi.nlm.nih.gov/pubmed/19171770
http://dx.doi.org/10.1085/jgp.200810081
work_keys_str_mv AT gingrichkevinj pentobarbitalproducesactivationandblockofa1b2g2sgabaareceptorsinrapidlyperfusedwholecellsandmembranepatchesdivergentresultscanbeexplainedbypharmacokinetics
AT burkatpaulm pentobarbitalproducesactivationandblockofa1b2g2sgabaareceptorsinrapidlyperfusedwholecellsandmembranepatchesdivergentresultscanbeexplainedbypharmacokinetics
AT robertswilliama pentobarbitalproducesactivationandblockofa1b2g2sgabaareceptorsinrapidlyperfusedwholecellsandmembranepatchesdivergentresultscanbeexplainedbypharmacokinetics